The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials

We evaluated the overall agreement between colposcopically directed biopsies and the definitive excisional specimens within the context of three clinical trials. A total of 737 women aged 16-45 who had a cervical biopsy taken within 6 months before their definitive therapy were included. Per-protoco...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2011
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24338
Acceso en línea:
https://doi.org/10.1002/ijc.25470
https://repository.urosario.edu.co/handle/10336/24338
Palabra clave:
Placebo
Wart virus vaccine
Adenocarcinoma in situ
Adolescent
Adult
Article
Cancer grading
Carcinoma in situ
Colposcopy
Correlation analysis
Diagnostic test accuracy study
Diagnostic value
Disease severity
Double blind procedure
Female
Human
Human tissue
Major clinical study
Papillomavirus infection
Phase 3 clinical trial
Priority journal
Randomized controlled trial
Sensitivity and specificity
Uterine cervix biopsy
Uterine cervix cancer
Uterine cervix carcinoma in situ
Adenocarcinoma
Adolescent
Adult
Cervical intraepithelial neoplasia
Cervix uteri
Colposcopy
Double-blind method
Female
Follow-up studies
Humans
Middle aged
Papillomaviridae
Papillomavirus infections
Papillomavirus vaccines
Placebos
Prognosis
Uterine cervical neoplasms
Vaginal smears
Young adult
Biopsy
Cervical cancer
Colposcopy
Hpv
Papillomavirus
Vaccine
viral
Dna
Rights
License
Abierto (Texto Completo)
Description
Summary:We evaluated the overall agreement between colposcopically directed biopsies and the definitive excisional specimens within the context of three clinical trials. A total of 737 women aged 16-45 who had a cervical biopsy taken within 6 months before their definitive therapy were included. Per-protocol, colposcopists were to also obtain a representative cervical biopsy immediately before definitive therapy. Using adjudicated histological diagnoses, the initial biopsies and the same day biopsies were correlated with the surgically excised specimens. The overall agreement between the biopsies taken within 6 months of definitive therapy, and the definitive therapy diagnoses was 42% (weighted kappa = 0.34) (95% CI: 0.29-0.39). The overall underestimation of cervical intraepithelial neoplasia grade 2/3 or adenocarcinoma in situ (CIN2-3/AIS) and CIN3/AIS was 26 and 42%, respectively. When allowing for one degree of variance in the correlation, the overall agreement was 92% for CIN2-3/AIS. The overall agreement between the same day biopsy and definitive therapy specimen was 56% (weighted kappa = 0.41) (95% CI: 0.36-0.47), and the underestimation of CIN2-3/AIS was 57%. There were significant associations in the agreement between biopsies and excisional specimen diagnoses when patients were stratified by age, number of biopsies, lesion size, presence of human papillomavirus (HPV)16/18 and region. Of 178 diagnostic endocervical curettages performed, 14 (7.9%) found any HPV disease. Colposcopic accuracy improved when CIN2 and CIN3/AIS were grouped as a single predictive measure of high-grade disease. Colposcopy functioned well when allowed a one-degree difference between the biopsy and the surgical histologic interpretations, as done in clinical practice. Taking more than one biopsy improved colposcopic accuracy and could improve patient management. Copyright © 2010 UICC.